Key result
Proteomics identifies ~160 altered proteins, showing greater inflammation, coagulation, and calcification in CKD vs classical CVD.
Why the study?
The understanding of the molecular specificity distinguishing risk factors for classical CVD from CKD-related atherosclerosis is incomplete.
How do plasma proteome profiles and non-traditional atherosclerosis risk pathways differ between patients with chronic kidney disease-related atherosclerosis across CKD stages, patients with classical cardiovascular disease without renal dysfunction, and healthy volunteers?
Cross-Sectional (n=150)
No
How do plasma proteome profiles and non-traditional atherosclerosis risk pathways differ between patients with chronic kidney disease-related atherosclerosis across CKD stages, patients with classical cardiovascular disease without renal dysfunction, and healthy volunteers?
Answers are grounded in this paper and cite their sources.
Direct comparative plasma proteomics demonstrates that non-traditional risk pathways—inflammation, blood coagulation, oxidative stress, endothelial damage, and vascular calcification—are substantially more dysregulated in advanced CKD-related atherosclerosis than in classical non-renal cardiovascular disease.
The major cause of mortality in patients with chronic kidney disease (CKD) is atherosclerosis related to traditional and non-traditional risk factors. However, the understanding of the molecular specificity that distinguishes the risk factors for classical cardiovascular disease (CVD) and CKD-related atherosclerosis (CKD-A) is far from complete. In this study we investigated the disease-related differences in the proteomes of patients with atherosclerosis related and non-related to CKD. Plasma collected from patients in various stages of CKD, CVD patients without symptoms of kidney dysfunction, and healthy volunteers (HVs), were analyzed by a coupled label-free and mass spectrometry approach. Dysregulated proteins were confirmed by an enzyme-linked immunosorbent assay (ELISA). All proteomic data were correlated with kidney disease development and were subjected to bioinformatics analysis. One hundred sixty-two differentially expressed proteins were identified. By directly comparing the plasma proteomes from HVs, CKD, and CVD patients in one study, we demonstrated that proteins involved in inflammation, blood coagulation, oxidative stress, vascular damage, and calcification process exhibited greater alterations in patients with atherosclerosis related with CKD. These data indicate that the above nontraditional risk factors are strongly specific for CKD-A and appear to be less essential for the development of "classical" CVD.
No takes yet. Share an insight, caveat, or question.
Łuczak et al. (2016) conducted a cross-sectional in Atherosclerosis related and non-related to chronic kidney disease (CKD) (n=150). Chronic kidney disease-related atherosclerosis (CKD stages 1-2, 3-4, and 5) and classical cardiovascular disease vs. Healthy volunteers and classical cardiovascular disease patients without renal dysfunction was evaluated on Differentially expressed plasma proteins identified via label-free quantitative LC-MS/MS proteomics (fold change ≥1.5, minimum 2 peptides, >99% confidence) (p=<0.05). Label-free proteomics identified 162 differentially expressed plasma proteins, showing greater alterations in inflammation, coagulation, and calcification pathways in CKD than classical CVD.
Synapse has enriched 10 related papers. Consider them for comparative context: